Country: Индия
SKU:

Bresol TABLETS, 60 tab., HIMALAYA HERBALS

Brand: Индия

Bresol - a natural Ayurvedic herbal remedy for the treatment and prevention of bronchial asthma, allergic rhinitis, allergic bronchitis and other allergic respiratory diseases in children and adults.

Bresol contains natural, safe ingredients for the treatment of bronchial asthma and allergies, including well-known herbs for the effective treatment of various chronic respiratory disorders, such as Turmeric, Adhatoda Vasica and Holy Basil.

Bresol provides relief from acute and chronic allergic symptoms such as runny nose, nasal and chest congestion, and inflammation of the nasal and eye mucous membranes. Bresol has antihistamine, tonic and anti-inflammatory effects. Its bronchodilator, mucolytic (thins mucus) and expectorant properties help reduce symptoms of allergic bronchitis and bronchial asthma such as wheezing and shortness of breath.

Bresol facilitates breathing and helps prevent anaphylactic allergic shock (with regular use). Bresol reduces fatigue and improves sleep in patients with allergic rhinitis and bronchitis, and improves sleep in patients with bronchial asthma.

Composition: Exts. Haridra (Curcuma longa) 100.5mg Tulasi (Ocimum sanctum) 50mg Vasaka (Adhatoda vasica) 50mg Trikatu 8mg Triphala 8mg Vidanga (Embelia ribes) 8mg Musta (Cyperus rotundus) 8mg Tvak (Cinnamomum zeylanicum) 5mg Ela (Elettaria cardamomum) 5mg Patra (Cinnamomum tamala) 5mg Nagakesara (Mesua ferrea) 5mg Each teaspoonful (5ml) of Bresol contains: Exts. Haridra (Curcuma longa) 100.5mg Tulasi (Ocimum sanctum) 50mg Vasaka (Adhatoda vasica) 50mg Trikatu 8mg Triphala 8mg Vidanga (Embelia ribes) 8mg Musta (Cyperus rotundus) 8mg Tvak (Cinnamomum zeylanicum) 5mg Ela (Elettaria cardamomum) 5mg Patra (Cinnamomum tamala) 5mg Nagakesara (Mesua ferrea) 5mg

Application: 2 tablets 2 times a day, course 30 days. Children - 1 tablet 2 times a day; allergic rhinitis - course 2 weeks; allergic bronchitis and asthma - course up to 12-18 weeks.

Reviews 0
Rating 0

No reviews yet — be the first!